This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

TenX Keane Acquisition 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Xiaofeng Yuan

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	3.1yrs
CEO 소유권	n/a
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	데이터 없음

최근 관리 업데이트

Recent updates

CEO

Xiaofeng Yuan (52 yo)

3.1yrs

테뉴어

Mr. Xiaofeng Yuan has been Executive Director and Chairman of TenX Keane Acquisition Corp. since March 2021 and also serves as its Chief Executive Officer since July 2021. Mr. Yuan founded 38Fule Group and...

This company is no longer active

TenX Keane Acquisition 관리

관리 기준 확인 0/4

주요 정보

최근 관리 업데이트

Insufficient new directors

Recent updates

Citius Oncology, Inc. completed the acquisition of TenX Keane Acquisition (NasdaqGM:TENK) from 10XYZ Holdings LP, Hudson Bay Capital Management LP, Wolverine Asset Management, LLC, Mizuho Financial Group, Inc. and others in a reverse merger transaction.

TenX Keane Acquisition announced that it has received $0.066667 million in funding

TenX Keane Acquisition announced delayed 10-Q filing

TenX Keane Acquisition announced delayed annual 10-K filing

Insufficient new directors

TenX Keane Acquisition announced that it has received $0.2 million in funding

TenX Keane Acquisition announced delayed 10-Q filing

Citius Oncology, Inc. entered into an agreement and plan of merger to acquire TenX Keane Acquisition (NasdaqGM:TENK) from 10XYZ Holdings LP and others for approximately $730 million in a reverse merger transaction.

Citius Oncology, Inc. entered into an agreement and plan of merger to acquire TenX Keane Acquisition (NasdaqGM:TENK) from 10XYZ Holdings LP and others for approximately $730 million in a reverse merger transaction.

TenX Keane Acquisition announced that it has received $0.66 million in funding from 10XYZ Holdings LP

TenX Keane Acquisition announced delayed 10-Q filing

CEO

테뉴어